Le Lézard
Classified in: Health, Science and technology, Business, Covid-19 virus
Subjects: NPT, CSR, PSF, SRI

Besurance Corporation Launches People Helping People Initiative Through Besure Technology To Help Close Financial Gap During COVID-19


CALGARY, Alberta, March 19, 2020 /PRNewswire/ -- Nearly one week after World Health Organization declared the COVID-19 outbreak a global pandemic, Besurance Corporation has launched a not for profit, "People helping People" campaign using its besure technology to help close the financial gap for people that test positive for the virus. Besure is a community driven platform that allows people to come together and share risk when there is a gap between what people need and what is available through traditional insurance / government programs. Through besure, like minded individuals can come together and contribute into a "virtual jar" in order to co-create supplementary protection that would serve the community.

"This is what besure was designed for," says Karim Lalani, Managing Director - Besure. "The technology was designed and supplemented with actuarial tools to help people take matters into their own hands and create solutions as a community in a stable and structured environment. Besure is NOT insurance nor does it provide insurance. It is simply a technology platform that offers structure and discipline to help people protect themselves and their loved ones."

"The Government and our institutions are doing their best to manage this unprecedented crisis by lowering interest rates and injecting billions into programs for Canadians," explained Almin Kassamali, Chief Marketing Officer - Besure.

"Before the crisis, people were already economically fragile and facing uncertainty in their employment. EI rules have been modified to pay benefits earlier; however, people may need supplemental income if they are infected by the COVID-19 virus. EI supports employees but what about contractors? People who are self employed? We don't expect this initiative to solve the world's income problems.  We just want to help ease the burden."

Through besure, individuals actively at work between the ages of 20 and 54 may purchase coverage by contributing $10 (one time) for a coverage period of 2 months. This will offer a benefit of up to $1,000 during the quarantine/recovery period, while infected, to supplement their disposable income and help pay for basic essentials (groceries, utilities, rent/mortgage). Besure will return all unused funds (minus administrative costs) to individuals participating in the pool. This is a not for profit initiative.

Media inquires or further details, see our FAQ our contact us below:

Almin Kassamali
Chief Marketing Officer - Besurance Corporation
[email protected] || 403-804-9077

Karim Lalani
Managing Director - Besure
[email protected] || 403-401-2332

PRLog ID: www.prlog.org/12815167

 

SOURCE Besurance Corporation


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: